Lumos Pharma, Inc. (NASDAQ:LUMO) Q1 2023 Earnings Call Transcript May 3, 2023
Lumos Pharma, Inc. beats earnings expectations. Reported EPS is $-0.89, expectations were $-1.12.
Operator: Good afternoon, and welcome to Lumos Pharma’s Q1 2023 Financial Results Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded. I’ll now turn the call over to Lisa Miller, Senior Director of Investor Relations.
Lisa Miller: Thank you, operator. Before we proceed with...
